# OnCo record rejuv-second-uk-very-high-risk-breast-screening (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/rejuv-second-uk-very-high-risk-breast-screening/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "rejuv-second-uk-very-high-risk-breast-screening" ;
  schema:name "The UK very high risk breast screening protocol after chest radiotherapy"@en ;
  schema:alternateName "NHS very high risk breast screening"@en, "VHR breast screening"@en, "BARD"@en, "Breast screening after radiotherapy"@en ;
  schema:description "England runs a named screening programme for women who had radiotherapy to breast tissue when young, with exact ages and tests set out in its own documents. Surveillance begins at 25 or 30 depending on your age when irradiated, or eight years after the radiotherapy, whichever is later, and referral runs through a national dataset."@en ;
  schema:url <https://onco.cc/terms/rejuv-second-uk-very-high-risk-breast-screening/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Breast_cancer_screening> ;
  schema:citation <https://www.gov.uk/government/publications/breast-screening-higher-risk-women-surveillance-protocols/tests-and-frequency-of-testing-for-women-at-very-high-risk--2>, <https://www.gov.uk/government/publications/breast-screening-higher-risk-women-surveillance-protocols/protocols-for-surveillance-of-women-at-higher-risk-of-developing-breast-cancer> ;
  onco:tag "rejuvenation", "survivorship", "second-cancers", "breast", "screening", "uk" ;
  onco:related <https://onco.cc/terms/second-primary-breast-after-chest-radiotherapy/>, <https://onco.cc/terms/rejuv-second-screening-after-treatment-compared/>, <https://onco.cc/terms/rejuv-second-cancers-overview/> ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/mammography/>, <https://onco.cc/technologies/survivorship-care-plan/> ;
  onco:terms <https://onco.cc/terms/lymphoma-living-hodgkin-survivorship-screening/>, <https://onco.cc/terms/secondary-malignancy/>, <https://onco.cc/terms/second-cancers-after-radiotherapy/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-early-detection/>, <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-care-fragmentation/> .
